Literature DB >> 14504753

[Indications for and results of radical prostatectomy].

M Graefen1, P G Hammerer, A Haese, H Huland.   

Abstract

Radical prostatectomy represents the mainstay of therapy for clinically localized prostate cancer. The combination of diagnostic parameters such as PSA or biopsy Gleason grade in nomograms allows a safe prediction of pathologic stage and prognosis of the disease. Imaging techniques are useful in a subset of patients. International studies have proven a high cancer control rate of radical prostatectomy. A nerve-sparing modification of the operative technique does not compromise radicality of the procedure if patients are carefully selected. For this purpose simple and reliable algorithms are available.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504753     DOI: 10.1007/s00120-003-0429-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  28 in total

1.  Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma.

Authors:  Stefan Conrad; Markus Graefen; Uwe Pichlmeier; Rolf-Peter Henke; Andreas Erbersdobler; Peter G Hammerer; Hartwig Huland
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

2.  Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.

Authors:  M L Blute; E J Bergstralh; A W Partin; P C Walsh; M W Kattan; P T Scardino; J E Montie; J D Pearson; J M Slezak; H Zincke
Journal:  J Urol       Date:  2000-11       Impact factor: 7.450

3.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors:  M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

4.  Diagnosis, staging, and surgical treatment of prostatic carcinoma.

Authors:  W J Catalona; L V Avioli
Journal:  Arch Intern Med       Date:  1987-02

5.  Impotence following radical prostatectomy: insight into etiology and prevention.

Authors:  P C Walsh; P J Donker
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

6.  Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.

Authors:  M Graefen; J Noldus; U Pichlmeier; A Haese; P Hammerer; S Fernandez; S Conrad; R Henke; E Huland; H Huland
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

7.  Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

Authors:  Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

8.  A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy.

Authors:  M Graefen; A Haese; U Pichlmeier; P G Hammerer; J Noldus; K Butz; A Erbersdobler; R P Henke; U Michl; S Fernandez; H Huland
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

9.  Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma.

Authors:  Alexander Haese; Jonathan I Epstein; Hartwig Huland; Alan W Partin
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

10.  Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.

Authors:  H Zincke; J E Oesterling; M L Blute; E J Bergstralh; R P Myers; D M Barrett
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.